Try our mobile app
ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group” or “the Company”) NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING – 7 DECEMBER 2023 NO CHANGE STATEMENT Shareholders are advised that the audited annual financial statements of Aspen Holdings and the Group for the year ended 30 June 2023 are now available on our website at https://www.aspenpharma.com/investor-relations/. The annual financial statements contain no modifications to the Reviewed Condensed Group Financial Results that were published on 30 August 2023. The annual financial statements were audited by the Group’s external auditors, Ernst & Young Incorporated, and their unmodified audit report is presented in the 2023 audited annual financial statements and is available for inspection at the registered office of the Company. NOTICE OF THE ANNUAL GENERAL MEETING The annual general meeting will be held on Thursday, 7 December 2023 at 10:00 at Aspen’s head office (Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge in Durban), to transact the business as stated in the notice of the annual general meeting. The record date to participate and vote at the annual general meeting will be Friday, 1 December 2023 and the last day to trade to be eligible to vote and participate at the annual general meeting will be Tuesday, 28 November 2023. Aspen’s 2023 integrated report will be made available on our website at the end of October 2023 with a SENS announcement being released to notify shareholders in this regard. The notice and proxy of the annual general meeting will be posted to shareholders at this time, together with the summarised audited Group annual financial statements. Durban 4 October 2023 Sponsor Investec Bank Limited
